AbbVie plans four-part offering of senior notes via four bookrunners

By Devika Patel

Knoxville, Tenn., Sept. 13 – AbbVie Inc. plans to sell fixed-rate senior notes in four tranches, according to a 424B5 filing with the Securities and Exchange Commission.

The notes have a make-whole call and then a par call.

BofA Merrill Lynch, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BNP Paribas Securities Corp. are the bookrunners.

Proceeds will be used to redeem or repay at maturity all of the company’s $1 billion of 2% senior notes due Nov. 6, 2018, to prepay or repay at maturity its $2 billion term loan facility and for general corporate purposes.

AbbVie is a biopharmaceutical company is based in North Chicago, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.